BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2015

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three months ended March 31, 2015 and 2014 are as follows:

	Three Months Ended
	March 31,
	2015				2014
Laser systems		64.6	%			60.4	%
Imaging systems		3.1	%			10.4	%
Consumables and other		17.5	%			13.9	%
Services		13.8	%			15.0	%
License fees and royalties		1.0	%			0.3	%
Total revenue		100.0	%			100.0	%

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References + Details